Pen 360 Press [P360P].
The American biotechnology company Moderna announced this Monday that its COVID-19 vaccine candidate has met the pre-specified statistical criteria in the study protocol for efficacy, which showed 94.5 percent effectiveness, including in people infected with the SARS-CoV 2 virus, which causes the disease.